Antioxidants inhibit the expression of intercellular cell adhesion molecule-1 and vascular cell adhesion molecule-1 induced by oxidized LDL on human umbilical vein endothelial cells

Free Radical Biology and Medicine

Volumn 22, Issue 1-2, 1997, Pages 117-127

  Cominacini, Luciano ^a   Garbin, Ulisse ^a   Pasini, Anna Fratta ^a   Davoli, Anna ^a   Campagnola, Mario ^a   Contessi, Giovanni B ^a   Pastorino, Antonio M ^b   Lo Cascio, Vincenzo ^a  

^a UNIVERSITY OF VERONA   (Italy)

^b GSK   (Italy)

Author keywords

Adhesion molecules; Antioxidants; Atherosclerosis; Free radical; Human umbilical vein endothelial cells (HUVECs); Intercellular cell adhesion molecule 1 (ICAM 1); Oxidized LDL; Vascular cell adhesion molecule 1 (VCAM 1)

Indexed keywords

ALPHA TOCOPHEROL; ANTIOXIDANT; COPPER ION; ENDOTHELIAL LEUKOCYTE ADHESION MOLECULE 1; INTERCELLULAR ADHESION MOLECULE 1; LIPOXYGENASE; LOW DENSITY LIPOPROTEIN; OXIDIZED LOW DENSITY LIPOPROTEIN; PROBUCOL; THIOBARBITURIC ACID REACTIVE SUBSTANCE; VASCULAR CELL ADHESION MOLECULE 1;

ARTICLE; CONTROLLED STUDY; CYTOTOXICITY; GENE EXPRESSION; HUMAN; HUMAN CELL; LIPID OXIDATION; PRIORITY JOURNAL; UMBILICAL VEIN; VASCULAR ENDOTHELIUM;

GLYCINE MAX;

EID: 0029909002     PISSN: 08915849     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0891-5849(96)00271-7     Document Type: Article

References (38)

1. Ross R. The pathogenesis of atherosclerosis - An update. N. Engl. J. Med. 314:1986;488-500.
2. Bevilacqua M. P. Endothelial-leukocyte adhesion molecules. Annu. Rev. Immunol. 11:1993;767-804.
3. Springer T. A. Adhesion receptors of the immune system. Nature. 346:1990;425-434.
4. Lenardo M. J., Baltimore D. NF-κB: A pleiotropic mediator of inducible and tissue-specific gene control. Cell. 58:1989;227-229.
5. Satriano J. A., Shuldiner M., Hora K., Xing Y., Schlondorff D. Oxygen radicals as second messengers for expression of the monocyte chemoattractant protein, JE/MCP-1, and the monocyte colony-stimulating factor, CSF-1, in response to tumor necrosis factor-alpha and immunoglobulin G. J. Clin. Invest. 92:1993;1564-1571.
6. Avogaro P., Bittolo Bon G., Cazzolato G. Presence of a modified low density lipoprotein in humans. Arteriosclerosis. 8:1988;79-87.
7. Boyd H. C., Gown A. M., Wolfbauer G., Chait A. Direct evidence for a protein recognized by a monoclonal antibody against oxidatively modified LDL in atherosclerotic lesions from a Watanabe heritable hyperlipidemic rabbit. Am. J. Pathol. 135:1989;815-824.
8. Steinberg D., Parthasarathy M. D., Carew T. E., Khoo J. C., Witztum J. L. Beyond cholesterol. Modification of low-density lipoprotein that increases its atherogenicity. N. Engl. J. Med. 320:1989;915-924.
9. Rosenfeld M. E. Oxidized LDL affects multiple atherogenic cellular responses. Circulation. 83:1991;2137-2140.
10. Wiklund O., Mattson L., Bjornheden T., Camejo G., Bondjers G. Uptake and degradation of low density lipoproteins in atherosclerotic rabbit aorta: Role of local LDL modification. J. Lipid Res. 32:1991;55-62.
11. Palinsky W., Yla-Herttuala S., Rosenfeld M. E., Butler S. W., Socher S. A., Parthasarathy S. Antisera and monoclonal antibodies specific for epitopes generated during oxidative modification of low density lipoprotein. Arteriosclerosis. 10:1990;325-332.
12. Quinn M., Parthasarathy S, Fong L. G., Steinberg D. Oxidatively modified low density lipoproteins: A potential role in recruitment and retention of monocyte/macrophages during atherogenesis. Proc. Natl. Acad. Sci. USA. 84:1987;2995-2998.
13. Berliner J. A., Territo M. C., Sevanian A., Ramin S., Kim J. A., Bamshad B., Esterson M., Fogelman A. M. Minimally modified low-density lipoprotein stimulates monocyte endothelial interactions. J. Clin. Invest. 85: 1990;1260-1266.
14. Parhami F. F., Fang Z. T., Fogelman A. M., Andalibi A., Territo M. C., Berliner J. A. Minimally modified low density lipoprotein-induced inflammatory responses in endothelial cells are mediated by cyclic adenosine monophosphate. J. Clin. Invest. 92:1993;471-478.
15. Frostegard J., Haegerstrand A., Gidlund M., Nilsson J. Biologically modified LDL increases the adhesive properties of endothelial cells. Atherosclerosis. 90:1991;119-126.
16. Frostegard J., Wu R., Haegerstrand A., Patarroyo M., Lefvert A. K., Nilsson J. Mononuclear leukocytes exposed to oxidized low density lipoprotein secrete a factor that stimulates endothelial cells to express adhesion molecules. Atherosclerosis. 103:1993;213-219.
17. Jeng J. R., Chang C. H., Shieh S. M., Chiu H. C. Oxidized low-density lipoprotein enhances monocyte-endothelial cell binding against shear-stress-induced detachment. Biochim. Biophys. Acta. 1178:1993;221-227.
18. Khan B. V., Parthasarathy S. S., Alexander R. W., Medford R. M. Modified low density lipoprotein augment cytokine-activated vascular cell adhesion molecule-1 gene expression in human vascular endothelial cells. J. Clin. Invest. 95:1995;1262-1270.
19. Havel R. J., Eder M. A., Bragdon J. M. The distribution and chemical composition of ultracentrifugally separated lipoproteins in human serum. J. Clin. Invest. 34:1955;1345-1353.
20. Jaffe E. A., Nachman R. L., Becker C. G., Minick C. R. Culture of human endothelial cells derived from umbilical veins. J. Clin. Invest. 52:1973;2745-2752.
21. Smith C. W., Marlin S. D., Rothlein R., Toman C., Anderson D. C. Cooperative interactions of LFA-1 and Mac-1 with intercellular adhesion molecule-1 in facilitating adherence and transendothelial migration of human neutrophilis in vitro. J. Clin. Invest. 83:1989;2008-2017.
22. Cominacini L., Garbin U., Cenci B., Davoli A., Pasini C., Ratti E., Gaviraghi G., Lo Cascio V., Pastorino A. M. Predisposition to LDL oxidation during copper-catalyzed oxidative modification and its relation to alpha-tocopherol content in humans. Clin. Chim. Acta. 204:1991;57-68.
23. Lehmann J., Martin H. L. Improved direct determination of alpha- and gamma-tocopherol in plasma and platelets by liquid chromatography, with fluorescence detection. Clin. Chem. 28:1982;1345-1353.
24. Satonin D. K., Coutant J. E. Comparison of gas chromatography and high performance liquid chromatography for the analysis of probucol in plasma. J. Chromatogr. 380:1986;411-416.
25. 2 mimics cell-mediated oxidative modification. J. Lipid Res. 29:1988;745-755.
26. Aust S. D. Lipid peroxidation. Greenwald R. A. Handbook of methods for oxygen radical research. 1985;203-207 CRC Press, Inc, Boca Raton, FL.
27. Craig E. T., Jackson R. L., Ohlweiler D. F., Ku G. Multiple lipid oxidation products in low density lipoproteins induce interleukin-1 beta release from human blood mononuclear cells. J. Lipid Res. 35:1994;417-427.
28. Smith P. K., Krohn R. I., Hermanson G. T., Mallia A. K., Gartner F. H., Provenzano M. D., Fujimoto E. K., Goeke N. M., Olson B. J., Klenk D. C. Measurement of protein using bicinchoninic acid. Anal. Biochem. 105:1985;293-299.
29. Landegren U. Measurement of cell numbers by means of the endogenous enzyme hexosaminidase: Application to detection of lymphokines and cell surface antigens. J. Immunol. Methods. 67:1984;379-385.
30. Esterbauer H., Rotheneder M., Striegl G., Waeg G., Ashy A., Sattler W., Jurgens G. Vitamin E and other lipophilic antioxidants protect LDL against oxidation. Fat Sci. Technol. 91:1989;316-324.
31. Esterbauer H., Gebicki J., Puhl H., Jurgens G. The role of lipid peroxidation and antioxidants in oxidative modifications of LDL. Free Radic. Biol. Med. 13:1992;341-390.
32. Esterbauer H., Quehenberger O., Jurgens G. Oxidation of human low density lipoprotein with special attention to aldehydic lipid peroxidation products. Rice-Evans C., Halliwell B. Free radicals: Methodology and concepts. 1988;243-268 The Richelieu Press, London.
33. Esterbauer H. S., Striegl G., Puhl H., Oberreither S., Rotheneder M., El-Saadani M., Jurgens G. The role of vitamin E and carotenoids in preventing oxidation of low-density lipoprotein. Ann. NY. Acad. Sci. 570:1989;254-267.
34. Regnstrom J. N., Nilsson J., Tornavall P., Landou C., Hamsten A. Susceptibility to low-density lipoprotein oxidation and coronary atherosclerosis in man. Lancet. 339:1992;1183-1186.
35. Cominacini L., Garbin U., Pastorino M., Davoli A., Campagnola M., De Santis A., Pasini C., Faccini G. B., Trevisan M. T., Bertozzo L., Pasini F., Lo Cascio V. Predisposition to LDL oxidation in patients with and without angiographically established coronary artery disease. Atherosclerosis. 99:1993;63-70.
36. Maggi E., Marchesi E., Ravetta V., Falaschi F., Finardi G., Bellomo G. Low-density lipoprotein oxidation in essential hypertension. J. Hypertension. 11:1993;1103-1111.
37. Marui N., Offermann M. K., Swerlick R., Kunsch C., Rosen C. A., Ahmad M., Alexander R. W., Medford R. M. Vascular cell adhesion molecule-1 (VCAM-1) gene transcription and expression are regulated through and antioxidant-sensitive mechanism in human vascular endothelial cells. J. Clin. Invest. 92:1993;1866-1874.
38. Weber C., Erl W., Pietsch A., Strobel M., Loms Ziegler-Heitbrock H. W., Weber P. C. Antioxidants inhibit monocyte adhesion by suppressing nuclear factor-κB mobilization and induction of vascular cell adhesion molecule-1 in endothelial cells stimulate to generate radicals. Arterioscler. Thromb. 14:1994;1665-1673.